National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 69748-69749 [2011-28956]

Download as PDF 69748 Federal Register / Vol. 76, No. 217 / Wednesday, November 9, 2011 / Notices This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Neurodevelopment and Neural Disorders. Date: November 28, 2011. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Laurent Taupenot, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4811, MSC 7850, Bethesda, MD 20892, (301) 435– 1203, taupenol@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Biomedical Imaging. Date: December 2, 2011. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Malgorzata Klosek, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4188, MSC 7849, Bethesda, MD 20892, (301) 435– 2211, klosekm@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: November 2, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–29019 Filed 11–8–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health emcdonald on DSK5VPTVN1PROD with NOTICES Notice of Closed Meeting Center for Scientific Review Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning VerDate Mar<15>2010 18:04 Nov 08, 2011 Jkt 226001 individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cell Biology. Date: November 22, 2011. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Wallace Ip, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5128, MSC 7840, Bethesda, MD 20892, (301) 435– 1191, ipws@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: November 1, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–28959 Filed 11–8–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, The Infant Immune System: Implications for Vaccines and Response to Infections. Date: December 1–2, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Salons AB, Bethesda, MD 20892. PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Contact Person: Lakshmi Ramachandra, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700–B Rockledge Drive, MSC–7616, Room 3264, Bethesda, MD 20892–7616, (301) 496– 2550, Ramachandral@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 2, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–28957 Filed 11–8–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel,Biomed—ISS. Date: January 18, 2012. Time: 11 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Democracy II, 6707 Democracy Blvd. 900, Bethesda, MD 20892,(Telephone Conference Call). Contact Person: Ruth Grossman, DDS, Scientific Review Officer, National Institute of Biomedical Imagin and Bioengineering, National Institutes of Health,6707 Democracy Boulevard, Rm. 960, Bethesda, MD 20892,(301) 496–8775, grossmanrs@mail.nih.gov. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel,2012 P41 Reverse Site Visit. Date: February 26–27, 2012. Time: 6 p.m. to 9 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\09NON1.SGM 09NON1 Federal Register / Vol. 76, No. 217 / Wednesday, November 9, 2011 / Notices Place: Hyatt Regency Bethesda, One Bethesda Metro Station, Bethesda, MD 20814. Contact Person: Ruth Grossman, DDS, Scientific Review Officer, National Institute of Biomedical Imagin and Bioengineering, National Institutes of Health,6707 Democracy Boulevard, Rm. 960, Bethesda, MD 20892,(301) 496–8775, grossmanrs@mail.nih.gov. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel,2012 P41 Site Visit. Date: March 28–30, 2012. Time: 6 p.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: InterContinental Chicago, 505 North Michigan Avenue, Chicago, IL. Contact Person: Ruth Grossman, DDS, Scientific Review Officer, National Institute of Biomedical Imagin and Bioengineering, National Institutes of Health,6707 Democracy Boulevard, Rm. 960, Bethesda, MD 20892,(301) 496–8775, grossmanrs@mail.nih.gov. Dated: November 2, 2011. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–28956 Filed 11–8–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Office of the Secretary [Docket No. DHS–2011–0078] Privacy Act of 1974; Department of Homeland Security United States Coast Guard-029 Notice of Arrival and Departure System of Records Privacy Office, DHS. Notice of Privacy Act system of AGENCY: ACTION: records. In accordance with the Privacy Act of 1974, the Department of Homeland Security proposes to update and reissue an existing system of records titled, ‘‘Department of Homeland Security United States Coast Guard-029 Notice of Arrival and Departure System of Records.’’ This system of records allows the Department of Homeland Security/United States Coast Guard to facilitate the effective and efficient entry and departure of vessels into and from the United States and assist with assigning priorities for conducting maritime safety and security missions in accordance with international and United States regulations. As a result of the biennial review of this system, records have been updated to include cargo within the purpose and record source categories. This updated system will be included in emcdonald on DSK5VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 18:04 Nov 08, 2011 Jkt 226001 the Department of Homeland Security’s inventory of record systems. The Privacy Act exemptions for this system remain unchanged. DATES: Submit comments on or before December 9, 2011. This system will be effective December 9, 2011. ADDRESSES: You may submit comments, identified by docket number DHS– 2011–0078 by one of the following methods: • Federal e-Rulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Fax: (703) 483–2999. • Mail: Mary Ellen Callahan, Chief Privacy Officer, Privacy Office, Department of Homeland Security, Washington, DC 20528. • Instructions: All submissions received must include the agency name and docket number for this rulemaking. All comments received will be posted without change to https:// www.regulations.gov, including any personal information provided. • Docket: For access to the docket to read background documents or comments received go to https:// www.regulations.gov. FOR FURTHER INFORMATION CONTACT: For general questions please contact: Marilyn Scott-Perez (202) 475–3515 Privacy Officer, United States Coast Guard, 2100 2nd Street SW., Stop 7101, Washington, DC 20593. For privacy issues contact: Mary Ellen Callahan (703) 235–0780, Chief Privacy Officer, Privacy Office, U.S. Department of Homeland Security, Washington, DC 20528. SUPPLEMENTARY INFORMATION: I. Background In accordance with the Privacy Act of 1974, 5 U.S.C. 552a, the Department of Homeland Security (DHS) United States Coast Guard (USCG) proposes to update and reissue an existing DHS system of records titled, ‘‘DHS/USCG–029 Notice of Arrival and Departure (NOAD) System of Records.’’ USCG collects information related to NOAD for U.S. vessels in commercial service and all foreign vessels bound for or departing from ports or waterways within the United States. This information is maintained within the Ship Arrival Notification System (SANS), as well as other USCG systems used for screening and vetting of vessels, primarily, but not exclusively, through Marine Information for Safety and Law Enforcement (MISLE), DHS/ USCG–013, June 25, 2009, 74 FR 30305 and the Maritime Awareness Global Network (MAGNet) System of Records Notice, DHS/USCG–061, May 15, 2008, PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 69749 73 FR 28143. Information is retrieved from the SANS by vessel and not by personal identifier; however, USCG uses the information taken from the SANS in other systems to conduct screening and vetting of individuals pursuant to its mission for protecting and securing the maritime sector. The information that is required to be collected and submitted through Electronic Notice of Arrival and Departure (eNOAD) can be found on routine arrival/departure documents that passengers and crewmembers must provide to DHS when entering or departing the United States. eNOAD information includes complete name, date and place of birth, gender, country of citizenship, travel/mariner document type, number and country of issuance, expiration date, country of residence, status on board the vessel, and U.S. destination address (except for U.S. Citizens, lawful permanent residents, crew and those in transit). Additionally, vessel carriers and operators must provide the vessel name, vessel country of registry/flag, International Maritime Organization (IMO) number or other official number, voyage number, date of arrival/ departure, and foreign port where the passengers and crew members began/ terminate their sea transportation to the United States. USCG will collect vessel particulars that are submitted by the vessel owner, agent, master, operator, or person in charge of a vessel in advance of a vessel’s arrival or departure from the U.S. The information will be used to perform counterterrorism, law enforcement, safety and security queries to identify risks to the vessel or to the United States. The purpose of the information collection is to assess risk to vessels arriving to or departing from a U.S. port and to identify vessels that may pose a safety or security risk to the United States. The information collection allows USCG to facilitate the effective and efficient entry and departure of vessels into and from the U.S. and assist the USCG with assigning priorities while conducting maritime safety and security missions in accordance with international and U.S. regulations. NOAD information is maintained for a period of no more than ten years or when no longer needed, whichever is longer, from the date of collection at which time the data is deleted. Should derogatory information be discovered by USCG either through TECS or USCG’s own sources, such information would be communicated either through USCG’s MAGNet, the Coast Guard E:\FR\FM\09NON1.SGM 09NON1

Agencies

[Federal Register Volume 76, Number 217 (Wednesday, November 9, 2011)]
[Notices]
[Pages 69748-69749]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-28956]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel,Biomed--ISS.
    Date: January 18, 2012.
    Time: 11 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Democracy II, 6707 
Democracy Blvd. 900, Bethesda, MD 20892,(Telephone Conference Call).
    Contact Person: Ruth Grossman, DDS, Scientific Review Officer, 
National Institute of Biomedical Imagin and Bioengineering, National 
Institutes of Health,6707 Democracy Boulevard, Rm. 960, Bethesda, MD 
20892,(301) 496-8775, grossmanrs@mail.nih.gov.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel,2012 P41 Reverse Site Visit.
    Date: February 26-27, 2012.
    Time: 6 p.m. to 9 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 69749]]

    Place: Hyatt Regency Bethesda, One Bethesda Metro Station, 
Bethesda, MD 20814.
    Contact Person: Ruth Grossman, DDS, Scientific Review Officer, 
National Institute of Biomedical Imagin and Bioengineering, National 
Institutes of Health,6707 Democracy Boulevard, Rm. 960, Bethesda, MD 
20892,(301) 496-8775, grossmanrs@mail.nih.gov.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel,2012 P41 Site Visit.
    Date: March 28-30, 2012.
    Time: 6 p.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: InterContinental Chicago, 505 North Michigan Avenue, 
Chicago, IL.
    Contact Person: Ruth Grossman, DDS, Scientific Review Officer, 
National Institute of Biomedical Imagin and Bioengineering, National 
Institutes of Health,6707 Democracy Boulevard, Rm. 960, Bethesda, MD 
20892,(301) 496-8775, grossmanrs@mail.nih.gov.


    Dated: November 2, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2011-28956 Filed 11-8-11; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.